newsfilter
← Latest News
Business Wire·

OS Therapies Clarifies CUSIP of Common Stock

OS Therapies (NYSE:OSTX) ("OS Therapies" or "the Company"), an ADC and Immunotherapy research and clinical-stage biopharmaceutical company, today provided a clarification for market participants, specifically brokerage